Skip to main content

Table 2 Breakdown of patients in detail

From: Recombinant activated factor VII (rFVIIa) in refractory haemorrhage for non-haemophiliacs: an eleven-year single-centre experience

(a) for all occasions

 

24-hour outcome

Day-2 – Day-30 outcome

Overall 30-day outcome

Total

n

Survivors

n (%)

Deaths

n (%)

Survivors

n (%)

Deaths

n (%)

Survivors

n (%)

Deaths

n (%)

76

60 (78.9)

16 (21.1)

34 (56.7)

26 (43.3)

34 (44.7)

42 (55.3)

(b) according to causes of bleeding

Indications

Total

24-hour outcome

Day-2 – Day-30 outcome

Overall 30-day outcome

 

n

Survivors

n (%)

Deaths

n (%)

Survivors

n (%)

Deaths

n (%)

Survivors

n (%)

Deaths

n (%)

Trauma

22

17 (77.3)

5 (22.7)

11 (64.7)

6 (35.3)

11 (50)

11 (50)

Peripartum

4

3 (75)

1 (25)

3 (100)

0 (0)

3 (75)

1 (25)

Surgery bleedings

9

7 (77.8)

2 (22.2)

3 (42.9)

4 (57.1)

3 (33.3)

6 (66.7)

Medical

41

33 (80.5)

8 (19.5)

17 (51.5)

16 (48.5)

17 (41.5)

24 (58.5)